Lam ResearchLRCX
Makes the deposition and etching machines that build up and carve the layers of a chip during manufacturing.
By financial year
| Figure | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Income | |||||
| Revenue | $17.2bn | $17.4bn | $14.9bn | $18.4bn | $23.2bn |
| Gross profit | $7.9bn | $7.8bn | $7.1bn | $9.0bn | $11.7bn |
| Operating income | $5.4bn | $5.2bn | $4.3bn | $5.9bn | $8.2bn |
| Net income | $4.6bn | $4.5bn | $3.8bn | $5.4bn | $7.3bn |
| Earnings per share (diluted) | $3.27 | $3.32 | $2.90 | $4.15 | $5.76 |
| Cash flow | |||||
| Cash from operations | $3.1bn | $5.2bn | $4.7bn | $6.2bn | $5.9bn |
| Capital spending | $546m | $502m | $397m | $759m | $966m |
| Free cash flow | $2.6bn | $4.7bn | $4.3bn | $5.4bn | $4.9bn |
| Share buybacks | $3.9bn | $2.0bn | $2.8bn | $3.4bn | $3.9bn |
| Balance sheet (at the end of the period) | |||||
| Cash and investments | $3.5bn | $5.3bn | $5.8bn | $6.4bn | $5.6bn |
| Total debt | $5.0bn | $5.0bn | $5.0bn | $4.5bn | $3.7bn |
| Net debt (debt less cash) | $1.4bn | −$372m | −$880m | −$1.9bn | −$1.9bn |
| Shareholders’ equity | $6.3bn | $8.2bn | $8.5bn | $9.9bn | $12.5bn |
| Shares (diluted average) | 1.41bn | 1.36bn | 1.32bn | 1.29bn | 1.26bn |
By quarter
| Figure | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | $4.4bn | $4.7bn | $5.2bn | $5.3bn | $5.3bn | $5.8bn | $6.7bn | $8.2bn |
| Gross profit | $2.1bn | $2.3bn | $2.6bn | $2.7bn | $2.7bn | $2.9bn | $3.5bn | $4.3bn |
| Operating income | $1.3bn | $1.6bn | $1.7bn | $1.8bn | $1.8bn | $2.0bn | $2.5bn | $3.3bn |
| Net income | $1.2bn | $1.3bn | $1.7bn | $1.6bn | $1.6bn | $1.8bn | $2.3bn | $2.8bn |
| Earnings per share (diluted) | $0.92 | $1.03 | — | $1.24 | $1.26 | $1.45 | — | $2.19 |
| Cash flow | ||||||||
| Cash from operations | $742m | $1.3bn | $2.6bn | $1.8bn | $1.5bn | $1.1bn | $1.5bn | $3.5bn |
| Capital spending | $188m | $288m | $172m | $185m | $261m | $332m | $189m | $258m |
| Free cash flow | $554m | $1.0bn | $2.4bn | $1.6bn | $1.2bn | $810m | $1.3bn | $3.2bn |
| Share buybacks | $698m | $435m | $1.3bn | $976m | $1.5bn | $1.2bn | $247m | $1.0bn |
| Balance sheet (at the end of the period) | ||||||||
| Cash and investments | $5.7bn | $5.5bn | $6.4bn | $6.7bn | $6.2bn | $4.8bn | $5.6bn | $7.4bn |
| Total debt | $5.0bn | $4.5bn | $4.5bn | $4.5bn | $4.5bn | $3.7bn | $3.7bn | $3.7bn |
| Net debt (debt less cash) | −$683m | −$966m | −$1.9bn | −$2.2bn | −$1.7bn | −$1.0bn | −$1.9bn | −$3.7bn |
| Shareholders’ equity | $8.8bn | $9.5bn | $9.9bn | $10.2bn | $10.1bn | $10.6bn | $12.5bn | $13.9bn |
| Shares (diluted average) | 1.29bn | 1.29bn | — | 1.27bn | 1.26bn | 1.26bn | — | 1.26bn |
Charts and live prices are delayed, from TradingView. Market values use each company’s last trade on IEX at the previous close, times the shares in issue from its filings; company figures come from SEC filings. This is information, not investment advice. Where our market data comes from
Company logos are trademarks of their owners, shown only to identify them; the files are from Wikimedia Commons.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.